Psoriasis Clinical Trials

Showing 521-540 of 1,026 trials

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290

Study to evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-051 administered for 12 weeks in subjects with moderate to severe plaque psoriasis.

Plaque PsoriasisSkin Diseases

Akros Pharma Inc.13 participantsStarted Nov 2017

Fountain Valley, California, United States • Fremont, California, United States • Tampa, Florida, United States +13 more locations

COMPLETEDNA

Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis

NCT04989296

This study is the first to quantify the level of NF-kB translocation in lymphocyte populations in children and adolescents with psoriasis of varying severity.

Psoriasis Vulgaris

National Medical Research Center for Children's Health, Russian Federation120 participantsStarted Sep 2018

Moscow, Russia

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis

Related Searches

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

A Clinical Investigation With Epaderm® Cream

PSOREAL - Managing PSOriasis in the REAL World

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast

Psoriatic Oligoarthritis Intervention With Symptomatic thErapy

Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

UCB Cimzia Pregnancy Follow-up Study